Voices of MRD: Where We’ve Been, Where We Are Now and Where We’re Going
On January 27, 2021, the MRD Testing Collaborative hosted a virtual event for patients, advocates, health care professionals and industry leaders about MRD testing. Hear from Dr. Rafael Fonseca, MD of the Mayo Clinic; Dr. Haifaa Abudlhaq, MD of UCSF and UCSF Fresno; and Pat Garcia-Gonzalez, of The Max Foundation as they discuss the state of MRD testing, including the impact of COVID-19 on care, and what may be expected in the future.
The Importance of MRD Testing
MRD tests, which are usually used in the treatment of blood cancers, can determine how well a cancer treatment is working, and can be helpful in choosing future treatment plans. Hear from members of the MRD Testing Collaborative on the importance of these tests for patients.
MRD Testing: What Patients Should Know
Are you a blood cancer patient or do you know someone who is going through treatment for blood cancer? Going through any type of cancer treatment can be overwhelming. Hear from members of the MRD Testing Collaborative on what blood cancer patients should know about MRD testing.
Putting MRD to the Test Now and In the Future: Panel Highlights
In December 2019, the MRD Testing Collaborative held a panel discussion on MRD testing: Putting MRD to the Test Now and in the Future. Hear from Dr. Elisabet Manasanch, MD of the MD Anderson Cancer Center; Dr. Ola Landgren, MD, PhD of Memorial Sloan-Kettering Cancer Center; and Zack Pemberton-Whiteley of Leukaemia Care.
About the MRD Testing Collaborative
Hear from our members about what they are excited to accomplish with the Collaborative and where to access information on MRD testing. Interested in joining us? Contact us at firstname.lastname@example.org.